Regulations.gov document
Determinations that Drugs were Not Withdrawn from Sale for Reasons of Safety or…
Notice · FDA-2011-P-0460 · posted Aug 30, 2011
Key facts
| Document ID | FDA-2011-P-0460-0003 |
|---|---|
| Title | Determinations that Drugs were Not Withdrawn from Sale for Reasons of Safety or Effectiveness: TALWIN COMPOUND Tablets (Aspirin; Pentazocine Hydrochloride), 325 Milligrams; Equivalent to 12.5 Milligram Base |
| Document type | Notice |
| Subtype | General Notice |
| Agency | FDA |
| Docket | FDA-2011-P-0460 |
| Posted | Aug 30, 2011 |
| Federal Register citation | 76 FR 53907 |
| FR document number | 2011-22145 |
| Effective date | Aug 30, 2011 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: